Citigroup’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $89K | Buy |
28,981
+3,336
| +13% | +$14.4K | ﹤0.01% | 4327 |
|
|
2025
Q4 | $91.3K | Buy |
25,645
+14,153
| +123% | +$86.7K | ﹤0.01% | 4357 |
|
|
2025
Q3 | $102K | Sell |
11,492
-46,633
| -80% | -$473K | ﹤0.01% | 4265 |
|
|
2025
Q2 | $536K | Sell |
58,125
-102,589
| -64% | -$876K | ﹤0.01% | 3582 |
|
|
2025
Q1 | $1.38M | Buy |
160,714
+67,237
| +72% | +$635K | ﹤0.01% | 3025 |
|
|
2024
Q4 | $1M | Buy |
93,477
+32,677
| +54% | +$251K | ﹤0.01% | 3365 |
|
|
2024
Q3 | $345K | Buy |
60,800
+7,291
| +14% | +$42.1K | ﹤0.01% | 3973 |
|
|
2024
Q2 | $226K | Sell |
53,509
-518,136
| -91% | -$2.1M | ﹤0.01% | 3822 |
|
|
2024
Q1 | $2.91M | Buy |
571,645
+468,957
| +457% | +$2.64M | ﹤0.01% | 2121 |
|
|
2023
Q4 | $956K | Sell |
102,688
-15,758
| -13% | -$108K | ﹤0.01% | 2857 |
|
|
2023
Q3 | $776K | Sell |
118,446
-5,614
| -5% | -$44.7K | ﹤0.01% | 2716 |
|
|
2023
Q2 | $1.01M | Sell |
124,060
-253,864
| -67% | -$2.18M | ﹤0.01% | 2840 |
|
|
2023
Q1 | $3.24M | Buy |
377,924
+166,608
| +79% | +$1.66M | ﹤0.01% | 1721 |
|
|
2022
Q4 | $1.96M | Sell |
211,316
-47,333
| -18% | -$506K | ﹤0.01% | 2056 |
|
|
2022
Q3 | $2.67M | Buy |
258,649
+76,186
| +42% | +$804K | ﹤0.01% | 1939 |
|
|
2022
Q2 | $1.83M | Buy |
182,463
+106,867
| +141% | +$1.01M | ﹤0.01% | 2171 |
|
|
2022
Q1 | $931K | Sell |
75,596
-141,353
| -65% | -$1.74M | ﹤0.01% | 3038 |
|
|
2021
Q4 | $3.76M | Buy |
216,949
+59,126
| +37% | +$1.12M | ﹤0.01% | 2078 |
|
|
2021
Q3 | $2.83M | Sell |
157,823
-173,627
| -52% | -$3.46M | ﹤0.01% | 2248 |
|
|
2021
Q2 | $7.58M | Buy |
331,450
+151,456
| +84% | +$2.24M | 0.01% | 1608 |
|
|
2021
Q1 | $2.69M | Buy |
179,994
+169,924
| +1,687% | +$1.86M | ﹤0.01% | 2284 |
|
|
2020
Q4 | $54K | Buy |
10,070
+7,549
| +299% | +$39.8K | ﹤0.01% | 5970 |
|
|
2020
Q3 | $11K | Sell |
2,521
-4,467
| -64% | -$19.2K | ﹤0.01% | 6538 |
|
|
2020
Q2 | $34K | Sell |
6,988
-5,863
| -46% | -$22.2K | ﹤0.01% | 6237 |
|
|
2020
Q1 | $40K | Buy |
12,851
+4,247
| +49% | +$14.8K | ﹤0.01% | 6167 |
|
|
2019
Q4 | $22K | Buy |
8,604
+5,480
| +175% | +$14.4K | ﹤0.01% | 6885 |
|
|
2019
Q3 | $10K | Sell |
3,124
-9,897
| -76% | -$28.6K | ﹤0.01% | 7053 |
|
|
2019
Q2 | $43K | Sell |
13,021
-3,413
| -21% | -$10.6K | ﹤0.01% | 6600 |
|
|
2019
Q1 | $50K | Buy |
16,434
+15,440
| +1,553% | +$36.9K | ﹤0.01% | 6341 |
|
|
2018
Q4 | $2K | Hold |
994
| – | – | ﹤0.01% | 7493 |
|
|
2018
Q3 | $3K | Sell |
994
-42,934
| -98% | -$121K | ﹤0.01% | 7548 |
|
|
2018
Q2 | $115K | Buy |
43,928
+37,957
| +636% | +$106K | ﹤0.01% | 5586 |
|
|
2018
Q1 | $16K | Buy |
5,971
+1,221
| +26% | +$3.45K | ﹤0.01% | 6849 |
|
|
2017
Q4 | $15K | Buy |
4,750
+3,642
| +329% | +$14.3K | ﹤0.01% | 6856 |
|
|
2017
Q3 | $5K | Sell |
1,108
-3,059
| -73% | -$13.6K | ﹤0.01% | 6841 |
|
|
2017
Q2 | $22K | Buy |
4,167
+1,268
| +44% | +$7.33K | ﹤0.01% | 6223 |
|
|
2017
Q1 | $16K | Sell |
2,899
-29,960
| -91% | -$155K | ﹤0.01% | 6355 |
|
|
2016
Q4 | $130K | Buy |
32,859
+30,180
| +1,127% | +$108K | ﹤0.01% | 5607 |
|
|
2016
Q3 | $10K | Sell |
2,679
-2,813
| -51% | -$11.8K | ﹤0.01% | 6522 |
|
|
2016
Q2 | $33K | Buy |
+5,492
| New | +$26.5K | ﹤0.01% | 5826 |
|
Other funds holding AVXL
VCM
SF
VPM